MUMBAI, India, Aug. 1 -- Intellectual Property India has published a patent application (202517059897 A) filed by Yeda Research And Development Co. Ltd.; Memorial Sloan Kettering Cancer Center; and Impact Biotech Ltd., Rehovot, Israel, on June 23, for 'photodynamic therapy of tumor by illumination from an endoluminal cavity.'
Inventor(s) include Scherz, Avigdor; Cohen, Yaniv; Preise, Dina; Yarmohamadi, Hooman; Solomon, Stephan; Sacks, Zachary; Kelsen, David; Boas, Franz Edward; Sasson, Keren; and Agemy, Lilach.
The application for the patent was published on Aug. 1, under issue no. 31/2025.
According to the abstract released by the Intellectual Property India: "Intraluminal photodynamic therapy (PDT) of a target tumor tissue that is carried out from within a blood vessel is disclosed. The PDT method may be a vascular-targeted photodynamic therapy (VTP) or any other form of PDT where photosensitizer concentration in the blood vessel endothelium is not phototoxic. The PDT of this disclosure is carried out from within a blood vessel in the vicinity of the target tissue or organ with a light-diffusing section of an irradiating optical fiber being positioned within the confines of an inflatable balloon section of a balloon catheter, which is inflated during irradiation to occlude blood flow."
The patent application was internationally filed on Nov. 27, 2022, under International application No.PCT/US2022/051023.
Disclaimer: Curated by HT Syndication.
